Results 171 to 180 of about 19,142 (214)

Healthcare utilization and costs in the first two years after heart failure diagnosis: an observational study by phenotype in southwestern Sweden. [PDF]

BMC Health Serv Res
Davidge J, Halling A, Agvall B.
europepmc   +1 more source

The VIRTUE Index: A Novel Echocardiographic Marker Integrating Right-Left Ventricular Hemodynamics in Acute Heart Failure. [PDF]

J Clin Med
Popescu DC, Ciobanu M, Țînț D, Nechita AC.   +3 more
europepmc   +1 more source

A refined approach of the tachypacing porcine model of heart failure. [PDF]

Front Cardiovasc Med
Berboth L, Ötvös J, Faragli A, De Marchi B, Longinotti-Buitoni G, Steendijk P, Attanasio P, Pieske BM, Post H, Heinzel F, Lo Muzio FP, Alogna A.   +11 more
europepmc   +1 more source

Myocardial work analysis during semi-supine stress echocardiography: exercise response patterns in heart failure patients and controls. [PDF]

Eur Heart J Imaging Methods Pract
Sahiti F, Cejka V, Güder G, Kerwagen F, Frantz S, Heuschmann PU, Störk S, Morbach C.   +7 more
europepmc   +1 more source

Heart failure types and predictors of 30-day rehospitalisation among patients aged ≥ 60 years with acute heart failure: a multicentre prospective study in Vietnam. [PDF]

BMC Cardiovasc Disord
Nguyen HT, Thai TH, Pham HTM.
europepmc   +1 more source

Predictors of reverse cardiac remodeling after sacubitril/valsartan in heart failure with reduced ejection fraction. [PDF]

Sci Rep
Yoon M, Lee SY, Park JJ, Lee SE, Cho HJ, Choi JO, Yoo BS, Kang SM, Lee S, Choi DJ.   +9 more
europepmc   +1 more source

Patient-Reported Health Status Among Patients With Heart Failure With Improved Ejection Fraction. [PDF]

J Am Heart Assoc
Vasti E, Zheng J, Kalwani NM, DeJong C, Bhatt AS, Ambrosy AP, Din N, Nallamshetty S, Sallam K, Heidenreich P, Sandhu AT.   +10 more
europepmc   +1 more source

Safety of Initiating Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Heart Failure or Type 2 Diabetes and a History of Urinary Tract Infections. [PDF]

Healthcare (Basel)
Rever J, Khalid N, Kulig C, Girgis J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

[Pharmacotherapy in HFrEF].

Deutsche medizinische Wochenschrift (1946), 2021
Since publication of the European Society guidelines for the diagnosis and treatment of acute and chronic heart failure in 2016, numerous studies provided new evidence how to further optimize heart failure therapy.Besides recent device-based therapeutic options, promising new drug developments give a glimmer of hope that the prognosis of this ...
Gülmisal, Güder, Stefan, Frantz
openaire   +1 more source

HFrEF phenotyping in real life

European Heart Journal, 2023
Abstract Background In May 2021 an HFA position paper[1] by Rosano GMC et al. classified patients with heart failure with reduced ejection fraction (HFrEF) into 11 phenotypes based on blood pressure, heart rate, renal function, potassium level and rhythm and assigned them to different prescription ...
A Weidenhammer, S Prausmueller, N Panagiotides, H Arfsten, G Heitzinger, G Spinka, A Barkhudaryan, P Bartko, M Huelsmann, N Pavo   +9 more
openaire   +1 more source